Deal activity by volume related to cloud increased by 28% year-on-year in 2022 in the medical industry  

Analysis of the key themes driving deal activity reveals that cloud accounted for 353 medical deals between 2018 and 2022, worth a total value of $51,688m, according to GlobalData’s Deals database covering mergers and acquisitions, private equity, venture financing, equity offerings and partnerships.  

The $200m venture financing issue by DNAnexus was the largest disclosed deal in 2022, while the $29,600m acquisition of Cerner by Oracle was the largest disclosed deal in 2021.  

In volume terms, cloud-related deal activity increased by 28% year-on-year in 2022, whereas it decreased by 32% year-on-year in 2021.

Venture financing accounted for the highest number of deals in the last five years, with 171 deals, followed by partnerships (73 deals) and equity offerings (38 deals).

The top financial advisors supporting deals related to cloud in the medical industry in the last five years in terms of value were Goldman Sachs, Centerview Partners, J.P. Morgan Securities, Citigroup, and Evercore.

The top legal advisors supporting deals related to cloud in the medical industry in the last five years in terms of value were Latham & Watkins; Kirkland & Ellis; Fried, Frank, Harris, Shriver & Jacobson; Hogan Lovells International; and Morgan, Lewis & Bockius.

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.  

GlobalData’s Deals database provides comprehensive coverage across industries tracking market activity of global mergers & acquisitions, including asset acquisitions/divestments; private equity deals (PE); venture finance deals (VC); equity offerings, including IPOs, follow-on offerings, and private placements; debt offerings, including private placements, ESG bonds and loans; partnerships; and licensing agreements.  

 This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumored deals.